Inactive and Overweight men and women, 21 to 50 years of age needed for research study

UVA Tracking #
HSR200065
Principal Investigator
Zhenqi Liu
Contact
Leona Hartline
Contact Email
Contact Phone
434.924.5247
Official Trial Title
Effects of Exercise and GLP-1R Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults with Metabolic Syndrome
Study Description

UVA Health System, Department of Internal Medicine, Division of Endocrinology is conducting a clinical research study. We want to learn more about how exercise training and an investigational drug that controls blood sugar, affect blood vessels in skeletal and cardiac muscle. You may be eligible if you are 21-50 years of age and have 3 of the 4 following characteristics: 1) overweight; 2) high blood pressure; 3) high fasting blood sugar ( but not diabetic); and /or 4) high cholesterol. You must be a nonsmoker, a non-exerciser, and have never taken the drug Liraglutide

Participation involves a 24-week treatment period. Participants are randomized to either 1)control group, 2) an exercise program, 3) taking the study drug, or 4) an exercise program combined with taking the study drug.
There are 5 outpatient visits:
- 3 outpatient visits (lasting about 1 to 2 hours).
- 2 Outpatient visits (lasting about 9 hours each, and spaced 24 weeks apart).
All visits are during the week, and require blood draws. The study will take approx. 5 months to complete.

Study-related exercise training with a personal trainer, exams and blood labs are provided free of charge.

Compensation

$1,500 paid in installments.